Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

145.13
+11.818.86%
Post-market: 145.840.7114+0.49%19:59 EDT
Volume:87.32M
Turnover:12.92B
Market Cap:57.94B
PE:-18.12
High:159.47
Open:133.11
Low:132.42
Close:133.32
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.40
T/O Rate:23.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.57
PE(LYR):-19.99

Loading ...

Why Moderna Stock is the S&P 500's Big Loser Today

Dow Jones
·
Jul 09

Moderna is Maintained at Equal-weight by Morgan Stanley

Dow Jones
·
Jul 09

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Jul 09

Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says

MT Newswires Live
·
Jul 08

Stock Track | Moderna Plummets 5.26% Intraday Amid Analyst Bearishness and Profit-Taking Pressure

Stock Track
·
Jul 08

Movement Alert|Moderna Falls 5.04% in Regular Trading, Bank of America Maintains Underperform Rating as Profit-Taking Pressure Persists

Market Focus
·
Jul 08

Moderna price target raised to $39 from $33 at Morgan Stanley

TIPRANKS
·
Jul 08

Moderna appoints Michael McDonnell to Board of Directors

TIPRANKS
·
Jul 08

Moderna Appoints Former Biogen CFO Michael Mcdonnell to Board, Audit Committee

Reuters
·
Jul 08

Moderna: Appoints Michael Mcdonnell to Board of Directors

THOMSON REUTERS
·
Jul 08

Moderna, TG Therapeutics, Agios Pharmaceuticals Q2 Results May Face Increased Scrutiny, BofA Says

MT Newswires Live
·
Jul 07

Movement Alert|Moderna Falls 5.04% in Regular Trading, Bank of America Maintains Underperform Rating with Target Far Below Current Price

Market Focus
·
Jul 07

Moderna is Maintained at Underperform by B of a Securities

Dow Jones
·
Jul 07

Stock Track | Moderna Plummets 5.01% Intraday as BofA Maintains Underperform Rating Despite Price Target Increase

Stock Track
·
Jul 07

BofA Adjusts Price Target on Moderna to $38 From $34, Maintains Underperform Rating

MT Newswires Live
·
Jul 07

Moderna : Bofa Global Research Raises Price Objective to $38 from $34

THOMSON REUTERS
·
Jul 07

Moderna price target raised to $38 from $34 at BofA

TIPRANKS
·
Jul 07

Stock Track | Moderna Soars 5.13% Intraday on Flu Vaccine Approval Hopes and Analyst Upgrade

Stock Track
·
Jul 06

Movement Alert|Moderna Rises 5.13% in Regular Trading, Flu Vaccine Approval Expectations and Analyst Upgrade Sustain Rally

Market Focus
·
Jul 06

US Stock Market Today: S&P 500 Futures Climb As Growth Hopes And Volatility Ease

Simply Wall St.
·
Jul 06